José Guevara-Coto

768 total citations · 1 hit paper
13 papers, 400 citations indexed

About

José Guevara-Coto is a scholar working on Molecular Biology, Infectious Diseases and Neurology. According to data from OpenAlex, José Guevara-Coto has authored 13 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Neurology. Recurrent topics in José Guevara-Coto's work include COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). José Guevara-Coto is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). José Guevara-Coto collaborates with scholars based in Costa Rica, United States and Germany. José Guevara-Coto's co-authors include Rodrígo Mora, Ram Yogendra, Bruce K. Patterson, Javier Mora, Purvi Parikh, Edgar B. Francisco, Amruta Pise, Dennis T. Maglinte, Paul T. Scott and Emily Long and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and BMC Genomics.

In The Last Decade

José Guevara-Coto

13 papers receiving 392 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

2022 154 citations Bruce K. Patterson, Edgar B. Francisco et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by José Guevara-Coto

Since Specialization

Citations

This map shows the geographic impact of José Guevara-Coto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Guevara-Coto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Guevara-Coto more than expected).

Fields of papers citing papers by José Guevara-Coto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Guevara-Coto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Guevara-Coto. The network helps show where José Guevara-Coto may publish in the future.

Co-authorship network of co-authors of José Guevara-Coto

This figure shows the co-authorship network connecting the top 25 collaborators of José Guevara-Coto. A scholar is included among the top collaborators of José Guevara-Coto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Guevara-Coto. José Guevara-Coto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals 2025 ·Human Vaccines & Immunotherapeutics ·Bruce K. Patterson, Ram Yogendra, Edgar B. Francisco, José Guevara-Coto, (unknown), Amruta Pise, (unknown), (unknown), (unknown), (unknown), (unknown), Richard Vander Heide, Rodrígo Mora	4
2	Long COVID diagnostic with differentiation from chronic lyme disease using machine learning and cytokine hubs 2024 ·Scientific Reports ·Bruce K. Patterson, José Guevara-Coto, Javier Mora, Edgar B. Francisco, Ram Yogendra, Rodrígo Mora, (unknown), (unknown), Gary Kaplan, Amiram Katz, Joseph A. Bellanti	3
3	Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC) 2023 ·Frontiers in Medicine ·Bruce K. Patterson, Ram Yogendra, José Guevara-Coto, Rodrígo Mora, (unknown), (unknown), Purvi Parikh, (unknown), (unknown), (unknown), Gary Kaplan, Michael Zgoda	11
4	Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection breakdown → 2022 ·Frontiers in Immunology ·Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra, Emily Long, Amruta Pise, (unknown), Eric Hall, Mónica Herrera, Purvi Parikh, José Guevara-Coto, Timothy J. Triche, Paul T. Scott, (unknown), Dennis T. Maglinte, (unknown), Rodrígo Mora, Javier Mora	154
5	Multistability in Macrophage Activation Pathways and Metabolic Implications 2022 ·Cells ·(unknown), (unknown), José Guevara-Coto, Anne Régnier‐Vigouroux, Rodrígo Mora	41
6	MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer 2021 ·iScience ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), José Guevara-Coto, (unknown), (unknown), (unknown), Anne Régnier‐Vigouroux, Pedro Mendes, Rodrigo Mora-Rodríguez	4
7	Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning 2021 ·Frontiers in Immunology ·Bruce K. Patterson, José Guevara-Coto, Ram Yogendra, Edgar B. Francisco, (unknown), Amruta Pise, (unknown), Purvi Parikh, Javier Mora, Rodrígo Mora	125
8	Classifying and Understanding Tor Traffic Using Tree-Based Models 2020 ·(unknown), José Guevara-Coto, Adrián Lara	1
9	Evaluating hyper-parameter tuning using random search in support vector machines for software effort estimation 2020 ·(unknown), (unknown), José Guevara-Coto, Alejandra Martínez, (unknown)	32
10	Machine learning approaches for the identification of new driver-like genes using microarray expression profiles 2019 ·(unknown), (unknown), David Díaz, José Guevara-Coto	1
11	Analysis of Different Pre-Processing Techniques to the Development of Machine Learning Predictors with Gene Expression Profiles 2019 ·(unknown), (unknown), José Guevara-Coto	2
12	Protein sector analysis for the clustering of disease-associated mutations 2014 ·BMC Genomics ·José Guevara-Coto, Charles E. Schwartz, Liangjiang Wang	5
13	Bemisia tabaci Biotype Q is present in Costa Rica 2011 ·European Journal of Plant Pathology ·José Guevara-Coto, (unknown), (unknown), Rosemarie W. Hammond, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact